Preimplantation genetic diagnosis (PGD) allows the detection of genetic defects before implantation, thus circumventing the possible need for abortion. France's current legislation allows the practice of PGD under certain circumstances which include the prerequisite agreement of the French health authority. Unfortunately, to enact the pending 'bioethical law', voted in July 1994, a decree still needs to be published. So, for the moment, although we know that PGD should be authorized, its practice is currently impossible in France. In order to prepare for licensing, we are setting up the relevant technologies, by performing biopsy on mouse embryos and fluorescent in-situ hybridization (FISH) experiments on human lymphoblast cells. We briefly describe the French legal situation with regard to PGD and the work we have performed in this context to obtain the licensing to offer PGD to patients. After a period of preparation, 95.9% of biopsies were successful and up to 95.4% of the biopsied blastomeres were properly spread onto slides. Biopsied and control mouse embryos were reimplanted into pseudopregnant females and similar birth rates were obtained (34.4 and 30.9% respectively). In these experiments we noticed a birth delay of 12-24 h for the biopsied embryos compared with the controls. Furthermore, scanning electron microscopy of the biopsied embryos allowed assessment of the hole made by the Tyrode's acid. By intercrossing adults derived from biopsied embryos for two successive generations, it was shown that the biopsy did not generate defects affecting their reproductive ability. FISH experiments were performed using specific probes for chromosomes X, Y and 1 on nuclei spread by a conventional protocol or a Tween/HCl blastomere spreading protocol; in the latter case, slides with 1-5 cells were prepared. A similar percentage of correct X,Y,1,1 signal was obtained from all three types of spreading, varying from 85.5 to 89.9%.
Introduction
Preimplantation genetic diagnosis (PGD) offers an alternative to prenatal diagnosis (PND) for couples at risk of transmitting a genetic defect, and avoids the difficult decision of whether or not to terminate a pregnancy (Liebaers et al., 1992; Cui et al., 1994b; Lissens et al., 1996; Handyside and Delhanty, 1997) . PGD, involving in-vitro fertilisation (IVF), allows the transfer of unaffected embryos to the uterus. During this procedure, one or two blastomeres from 4-or 8-cell-stage embryos are biopsied and analysed either by polymerase chain reaction (PCR), allowing the sexing of the embryos or the detection of a specific mutation, or by fluorescence in-situ hybridization (FISH), allowing the sexing of the embryos or the detection of some aneuploidies. PGD has been practised since 1968 (Gardner and Edwards, 1968) and embryo biopsy in humans has been practised since 1990 (Handyside et al., 1990) . According to the Second International Symposium on Preimplantation Genetics (Chicago, USA, 1997) , 30 centres across the world offer this diagnostic procedure. Most countries have adopted a rather permissive legal position towards PGD, which is usually controlled by a national or local authority such as the Human Fertilisation and Embryology Authority (HFEA) in the UK or a local ethical committee in Belgium. There are two major exceptions to this situation: Germany, where the Embryo Protection Act strictly forbids the practice of PGD and research on human embryos, and France, where a specific law concerning PGD, was voted in July 1994. The current French legislation covering PGD (Law No. 94-654; Art. L. 162-17; July 1994) dictates the following conditions under which PGD can be practised: (i) centres must be licensed for PGD and for assisted reproductive technology and IVF, and their activity would be subject to an annual evaluation; (ii) the consulting couple must otherwise have a high probability of giving birth to a genetically affected child; (iii) the genetic defect must be of a particular severity and recognized as incurable at the time of diagnosis; (iv) the genetic anomaly must be fully characterized in the parents; (v) only the previously identified defect can be investigated; (vi) the couple must provide a written consent for the diagnosis.
Licences will be granted by the Ministry of Health in consultation with the 'National Commission of Medicine and Biology of Human Reproduction and Prenatal Diagnosis', a body which can be compared to the HFEA in its function. Furthermore, the practice of PGD may only be performed inside a multidisciplinary network licensed for PND, which concerns all relevant medical techniques (such as ultrasound screening or fetal cell sampling) allowing the detection in utero of an anomaly of a particular severity.
Unfortunately, to enact the pending law, a decree still needs to be published. So, for the present, although PGD should be authorized, its practice is currently impossible in France (Viville and Nisand, 1997 ). It appears that the aim of the health authorities will be to provide a limited number of licenses for this practice in France and to assign these licences to teams that have previously proven expertise in manipulating embryos and in performing molecular analysis from single cells. In view of this requirement, since research on human embryos was until recently prohibited in France (Viville and Nisand, 1997) , and for ethical reasons, we have started a training programme involving mouse blastomere biopsy and FISH experiments on human lymphoblast cells. With a view to setting up PGD for recessive X-linked diseases, based on sex determination, we present here our results obtained using FISH. We also show scanning electron microscopy pictures of the microsurgical hole required for biopsy and discuss how much this treatment with Tyrode's acid damages the zona pellucida. These experiments on biopsied embryos demonstrate a limited injury to the embryos by this treatment. In addition, using adults developing from embryos which had one or two blastomeres biopsied, we have studied the effect on reproductive ability.
Materials and methods

Embryo biopsies
Embryos from CD1 mice were collected on day 2.5 post-coitum in M2 medium (Sigma, Lyon, France), washed in M16 medium (Sigma) and kept in M16 at 37°C at 5% CO 2 . Half of the embryos were biopsied, the other half were used as controls. Embryo biopsies were performed as described by Hardy et al. (1990) on an inverted Nikon microscope using Leitz micromanipulators. Briefly, the embryos were maintained by gentle suction with a holding pipette. Then, using a thin pipette to deliver a stream of Tyrode's acid (pH 2.3), a hole was made in the zona pellucida. A third polished pipette was used in order to aspirate one or two blastomeres through the hole. Some of the biopsied blastomeres were then processed as described for FISH experiments Harper et al., 1994) .
Evaluation of biopsied embryos
After biopsy, the embryos were transferred into pseudopregnant female uteruses. Pups were weighed at birth and observed during the first 2 weeks of their life. Adults derived from biopsied or control embryos were intercrossed for two generations and the pups derived from these crosses were weighed at birth and observed for 2 weeks.
Scanning electron microscopy
Scanning electron microscopy (SEM) was performed as described previously by Nikas et al. (1996) on biopsied and control embryos. Briefly, embryos were fixed in 0.1 M sodium cacodylate buffer containing 1% glutaraldehyde and kept at 4°C for 1 week. The samples were then dehydrated through an ethanol series and dried according to the critical point method using CO 2 . In order to render the biopsy site visible, samples were mounted on a sharpened tip of a pencil. SEM was than performed using a Philips XL20 scanning electron microscope.
Human lymphoblasts and trophoblastic cell spreading
Human male lymphoblasts or human trophoblastic cells were spread as described previously for mouse and human blastomeres . Briefly, clean polylysine slides were labelled using a diamond pen prior to spreading. One to five lymphoblasts were washed three times in phosphate-buffered saline (PBS) and transferred to a small drop of spreading solution (0.01 N HCl, 0.1% Tween 20). The cells were viewed under an inverted Nikon microscope. After lysis of the cells was observed, the slides were left to air dry for 20 min and dehydrated through an ethanol series.
Control lymphoblasts
The FISH procedure and the quality of the probes used were tested using interphase nuclei from human male lymphoblasts treated with 0.075 M KCl, fixed with a methanol:acetic acid (3:1) solution and stored at -20°C until required. Cells were dropped onto a clean slide on the day of the experiment, post-fixed with the methanol:acetic acid (3:1) solution and a 70% acetic acid solution before being dehydrated through an ethanol series.
Human DNA probes Probes were specific for chromosome X (pBamX5), Y (pCY98) and 1 (pUC1,77). They were directly labelled by nick translation (Boehringer, Mannheim, Germany) with Cy3-dCTP (Amersham, Les Ullis, France) for the X chromosome probe, FITC-12-dUTP (Boehringer) for the Y chromosome probe and a mixture (1:1) FITC-12-dUTP and Rhodamine-4-dUTP (Amersham) for the chromosome 1 probe. Probes were dissolved in 60% formamide/2ϫ sodium chloride/sodium citrate (SSC) hybridization mixture and used at a final concentration of 1-2 ng/µl. FISH FISH was performed as described by Harper et al. (1994) . Slides were treated with pepsin (100 mg/ml) in 0.01 N HCl for 20 min at 37°C, rinsed twice in bi-distilled water and once in PBS and postfixed in 1% paraformaldehyde in PBS for 10 min at 4°C. The slides were then rinsed in PBS and twice in bi-distilled water and dehydrated through an ethanol series. The hybridization solution (60% formamide, 2ϫ SSC, 10% dextran) containing the three probes was applied to the slides under a circular coverslip (10 mm diameter). The probes and the nuclear DNA were denatured at 78°C for 3 min. Hybridization was performed in a dark moist chamber at 37°C for 1-2 h. Posthybridization washes were 5 min in 60% formamide/2ϫ SSC and 5 min in 2ϫ SSC at 42°C, followed by two 5 min washes in 4ϫ SSC/ 0.05% Tween 20 at room temperature. After dehydration through an ethanol series, slides were counterstained with 4Ј,6 diaminidino-2-phenylindol (DAPI) in antifading solution (Vector, Burlingame, USA). Signal analysis was performed on a Leica microscope according to the scoring criteria described by Hopman et al. (1988) .
Results
Mouse embryos biopsy
Embryo biopsies were performed on 492 embryos. One or two blastomeres were removed according to the developmental stage of the embryo (4-or 8-cells respectively) and/or ease of biopsy. In total, 31 series of biopsies, ranging from 10 to 31 embryos per series, were performed. Excluding a period of preparation and practice of the technique (six series), from a total of 369 embryos (25 series) we successfully biopsied 354 embryos (95.9%) and damaged 15 of them (4.1%). It is worth noting that a similar success rate of biopsy was obtained from compacted or non-compacted embryos using the same biopsy technique. From these experiments, 87.1% of the biopsied blastomeres were intact (see Table I for details). From six experiments, blastomeres were spread onto slides and visualized after a counterstain with DAPI. Out of 130 biopsied blastomeres, 116 blastomeres were intact and successfully spread and, of the 14 lysed, eight were still usable and successfully spread (see Table II ). This represents 95.4% of analysable blastomeres. Biopsied and control embryos were reimplanted into foster mothers. For these experiments, the embryos were not sorted according to their developmental stage. Therefore 4-, 8-and compacted 8-cell embryos were mixed together before implantation. Out of 24 series of reimplantations of biopsied embryos, 11 series were successful, which represents a total of 163 embryos reimplanted, and, for the control embryos, 12 out of 22 reimplantations were successful, which represents a total of 181 embryos reimplanted. From the successful reimplantation, a similar birth rate of pups after biopsy (34.4%) was obtained compared that of the control unbiopsied embryos (30.9%, see Table III ). None of the 56 pups born from biopsied embryos presented any visible malformations over the first 2 weeks of their life. Furthermore, the birth weight of the pups born from the biopsied embryos was similar to that of the control pups (see Table III ). It is worth noting that we observed a birth delay of 12-24 h for the biopsied embryos compared to the controls.
Finally, to examine the health of the offspring and to elucidate any genetic defects which may have been caused by the biopsy procedure, we backcrossed four adult couples born from biopsied embryos as well as three couples born from control embryos. F 2 crosses were performed using three couples derived from the F 1 crosses of biopsied animals. As for the first generation, these animals gave birth to normal size litters and normal weight pups when compared to the controls (see Table IV ). Of these pups, no malformations where visible during their first 2 weeks of life.
Scanning electron microscopy
Some of the biopsied and control embryos were subjected to SEM. In order to view the biopsy site, the embryos were attached to the sharpened carbon tip of a pencil. Figure 1 illustrates this strategy. The biopsied embryo at the tip of a pencil is visible in Figure 1a . Due to dehydration of the samples, the zona pellucida flattened onto the underlying blastomeres, giving a blackberry appearance to the sample (Figure 1b) and thus allowing the counting of the remaining cells. Figure 1c hole and the microvilli covering the blastomeres at this stage of development. Figure 2 illustrates the biopsy of 4-cell-stage embryos. The top panel (Figure 2a -c) represents a control embryo where the typical spongy structure of the zona pellucida is visible (Phillips and Shalgi, 1980) . Figure 2d -i shows two embryos biopsied at the 4-cell-stage at different enlargements. The hole is clearly visible, as are the underlying blastomeres with their typical microvilli (Nikas et al., 1996) . Figure 3d-l represents three 8-cell-stage biopsied embryos from which one or two blastomeres had been extracted (note in Figure  3j -l the presence of a polar body). These SEM experiments allowed us to visualize the diversity of the aspect of the hole, to measure the diameter of the hole precisely, which varies from 8 to 14 µm, and to show that Tyrode's acid does not affect the zona 1025 pellucida over a large area. Loss of the normal spongy looking zona pellucida was found only within 5 µm from the treatment site. It also illustrated that the remaining blastomeres did not seem to be affected by the treatment, since their appearance corresponded well to that previously described (Nikas et al., 1996) . at ϫ1500 the general aspect of the embryos is visible and the remaining blastomeres can be counted; (e, h and k) at ϫ5000 the hole is visible as well as the aspect of the zona pellucida close to the edge of the hole; (f, i and l) at ϫ10 000 the edge of the hole and the microvilli of the underlying blastomeres are easily visible. A polar body is visible in j and k (arrows) and in l.
FISH
In an initial set of experiments, one to five human male lymphoblasts were spread using the blastomere spreading technique onto slides. The nuclei were then hybridized with probes specific for chromosomes X, Y and 1. From a total of five series (comprising 10-15 slides), 239 nuclei were analysed, of which 238 of the nuclei gave a signal (99.6%). Of these, 87% gave the expected signal (X,Y,1,1); 1.3 % gave a signal corresponding to tetraploid cells and 5.4% gave a X,Y,1 signal probably corresponding to an overlapping signal for the chromosome 1. The rest of the nuclei presented an abnormal signal pattern (see Table V ). For each experiment a control slide was used, allowing comparison with FISH experiments of spread lymphoblasts. A total of 2409 nuclei were analysed and no significant differences were noted between the two types of experiments.
In the second set of experiments, only one lymphoblast was spread on each slide. From a total of eight series of 15 slides each, all of the 119 nuclei gave a signal, except one; 89.9% of them the expected X,Y,1,1; 5% gave a X,Y,1 signal; two tetraploid nuclei (1.7%) were detected and 3.3% gave an abnormal signal (see Table VI ). In the first experiment one nucleus was lost. It was noticed that it had a pale appearance 1026 during the spreading procedure instead of a dark appearance. This fact may explain the absence of this nucleus.
In order to control for the accuracy of the technique, we performed blind experiments with trophoblastic cells. These cells were obtained from chorionic villus sampling (CVS) and were karyotyped by the Cytogenetics Ward. Three to five cells from each sample were spread onto a slide using the blastomere technique, and hybridized with the three probes X, Y and 1. Eighteen samples were analysed and all of them were correctly sexed.
Discussion
Since, for ethical reasons and in view of the difficulty of the techniques involved, the practice of PGD has still to be considered as experimental, we have started a meticulous evaluation of the techniques using animal models and human cultured cells, in preparation towards working with human embryos. The expertise that we have now acquired makes us feel confident that we could offer PGD to couples who carry a high risk of transmitting an X-linked disease. We would like to suggest that the work outlined here might form the basis of a training programme for clinics seeking to offer PGD. The experiments presented here involve a large series of biopsies of mouse embryos and of FISH experiments on a limited number of human male lymphoblast cells. We have performed 492 biopsies on mouse embryos (4-to 8-cell stage), from which one or two blastomeres were removed. After a period of training, on a total of 369 embryos and 520 biopsied blastomeres, 95.9% of the embryos and Ͼ87.1% of the blastomeres were correctly biopsied (see Table I ). It is interesting to note that using the same conditions of biopsy without any pretreatment of the embryos in Ca 2ϩ -and Mg 2ϩ -free medium, biopsies of compacted embryos were almost as successful as those of non-compacted embryos. Unfortunately, the low number of biopsies performed on compacted embryos did not allow a proper statistical analysis. These results are comparable to others already published for mouse and human embryos Cui et al., 1993a,b; Griffin et al., 1994; Pierce et al., 1997) . From six biopsy experiments, blastomeres were spread onto slides and counterstained with DAPI. In total, 95.4% of the biopsied blastomeres were spread and 100% showed DAPI staining (see Table II ).
To test the quality of the micromanipulations, we have reimplanted biopsied and control embryos into pseudopregnant 1027 mice. A similar rate of birth was obtained from the biopsied (34.4%) and control (30.9%) embryos (see Table III ). This result suggests minimal damage to the biopsied embryos and compares favourably with previously published figures Cui et al., 1993a,b; George et al., 1994) . It is worth noticing that the birth of the biopsied embryos is delayed by 12-24 h compared to the control embryos. This could be related to the results of Tarin et al. (1992) , who observed a delay in the development of biopsied human embryos. A similar delay probably also takes place in the case of mouse embryos and because of the shortness of gestation, can still be observed at the end of the pregnancy. This point has not been fully investigated and would need more experiments to be confirmed. Furthermore, we have tested the health of animals born after the biopsy of one or two blastomeres by testing their ability to reproduce. Four adult couples from biopsied embryos and three couples from their offspring were used. No significant differences in reproductive success, compared to control animals, were noticed (see Table IV ). This experiment can potentially highlight any genetic defects, and the results suggest the absence of deleterious effects of the biopsy, although the number of animals tested was too limited to be categorical. Therefore, we are currently carrying out a large scale experiment involving a greater number of animals.
These results are in agreement with the work of Cui et al. (1993a Cui et al. ( , 1994a , who performed breeding experiments and a series of blood and histopathological analyses on mice derived from biopsied embryos and some gene analysis (Cui et al., 1993b) . No significant effect of the biopsy procedure was observed.
We performed SEM on some of the biopsied embryos. We showed the aspect of the hole made in order to biopsy one or two blastomeres. As can been seen in Figures 2 and 3 , the general aspect of the hole can vary but the size of it is very regular and the damage to the zona pellucida is limited to a small area. Close to the edge (5 µm) of the hole, the zona pellucida presents a normal texture. Furthermore, the underlying blastomeres, according to the aspect of the visible microvilli, do not seem to be affected by this treatment (Jurisicova et al., 1996; Nikas et al., 1996) .
This experiment supports the work of Phillips and Shalgi (1980) and Familiari et al. (1989) , who postulated, in contradiction to Nicosia et al. (1978) , that the general aspect of the zona pellucida does not change after fertilization and it keeps its characteristic sponge-like appearance. We also showed that at the 4-or 8-cell stage the zona pellucida still presents numerous fenestrations, thus giving a spongy appearance.
It is important to mention that different strategies for embryo biopsy exist (Tarin and Handyside, 1993) and that the use of laser beams to drill the zona pellucida either for assisted hatching or for blastomere biopsy represents an interesting alternative (Tadir et al., 1991; El-Danasouri et al., 1993; Rink et al., 1996) . It would be interesting to see if this method gives rise to more homogeneous holes. Such an approach would be much faster than the use of Tyrode's acid to dissolve the zona pellucida and it would not modify the composition of the medium in which the embryos stand. However, there are no clear data confirming the absence of any effect on embryo development, even if some reports suggest the innocuity of this method (El-Danasouri et al., 1993; Rink et al., 1996) . PGD also involves a molecular analysis of the biopsied blastomeres, which can be done either by PCR or by FISH. Therefore, we performed a large series of FISH experiments on human male lymphoblast cells. Male cells were used instead of female cells in order to test all three probes used in sexing embryos. Initially, 1-5 cells were spread onto a slide using the blastomere technique (Table V) , and in a second series of experiments only one cell was spread per slide and treated as blastomeres. During this latter experiment, out of 120 nuclei analysed, one was lost and all the others gave a signal, from which 89.9% were X,Y,1,1 as expected (see Table VI ). Experiments on human lymphocytes provided similar results, with a signal obtained in 95-100% of the cases, from which 87-95% gave the expected diploid signal (Griffin et al., 1992; Harper et al., 1994 Harper et al., , 1995 Laverge et al., 1997) . Our loss of a cell during the first experiment could be due either to a technical error or to a problem with the nucleus spread: it had a pale aspect compared to all the other nuclei, which usually take a dark aspect under the microscope during lysis. The fact 1028 that more cells gave the expected signal in the 1-cell experiments compared to the 1-to 5-cell experiments (89.9 versus 87%) could be explained by the fact that a more careful choice of the cell was made in the former case. It has been shown that the quality of the nucleus can greatly influence the outcome of a PCR reaction (Cui and Matthews, 1996) . We believe the same is true for our FISH experiments.
Finally, to assess our ability to diagnose the chromosomal content of a very limited numbers of cells, we performed blind experiments using CVS samples. Three to five trophoblastic cells per sample were spread onto slides and hybridized with the probes X, Y and 1. By this method, all 18 samples tested were correctly sexed when compared to the karyotypes performed in the Cytogenetics Ward. An alternative technique to FISH is the use of primed in-situ labelling (PRINS), which seems to be very promising (Pellestor et al., 1996) .
We have reached a point where we obtained an equivalent birth rate of normal pups from the biopsied embryos as controls, thus indicating that the biopsy procedure does not significantly affect embryo development. The FISH experiments performed on a unique human lymphoblast cell allow us to be confident in our capability of performing it on unique blastomeres. Therefore, we consider that we are ready to offer PGD, based on sex determination. Considering that there are approximately 200 X-linked diseases and that the majority of them are recessive, this is an important milestone. We are currently applying for a license to perform research on spare human embryos in order to finalize our preparation for the practice of PGD.
Although research on human embryos is now allowed in France under certain strict conditions, because of ethical considerations, we are currently practising 1-cell PCR technology on human lymphoblast cells. We should, therefore, soon be technically ready to also offer PGD for specific autosomal genetic diseases such as cystic fibrosis (mutation ∆F508) and spinal myotrophy.
